FDA 483 - BPL Plasma, Inc. - May 20, 2019
Discuss this record with AI
Document or profile
One record shows the event. A profile shows the pattern.
Buy this document for the source file and details behind this single event.
Choose full profile access to connect related records, sites, people, citations, and enforcement history in one view.
BPL Plasma, Inc. in El Paso, TX, was cited for three observations related to donor management and equipment procedures during an FDA inspection. The firm failed to notify donors of all infectious disease test results and did not follow its SOP for donor counseling. Additionally, the firm did not consistently adhere to manufacturer instructions for apheresis instrument cleaning and calibration, and improperly removed donor deferrals for adverse events without required follow-up.
ID · c9403753-6478-40e3-a256-f8ca74d178f7